Avecho Biotechnology Limited
AVEFF
$0.0045
-$0.0129-74.14%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.11% | -34.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.11% | -34.27% | |||
| Cost of Revenue | 2.12% | -55.31% | |||
| Gross Profit | 2.10% | -18.16% | |||
| SG&A Expenses | 2.12% | 85.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.11% | 77.73% | |||
| Operating Income | -2.12% | -180.36% | |||
| Income Before Tax | -2.12% | -172.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.12% | -172.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.12% | -172.06% | |||
| EBIT | -2.12% | -180.36% | |||
| EBITDA | -2.12% | -196.24% | |||
| EPS Basic | 0.00% | -200.00% | |||
| Normalized Basic EPS | 0.00% | -100.00% | |||
| EPS Diluted | 0.00% | -200.00% | |||
| Normalized Diluted EPS | 0.00% | -100.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.06% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||